Compton Capital Management Inc Amgen Inc Transaction History

Compton Capital Management Inc

$4.32 Billion
Q2 2023

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$225.79 - $275.2 $484,319 - $590,304	-2,145 Reduced 61.55%	1,340 $323,000
Q4 2022 Feb 14, 2023	SELL	$229.03 - $291.01 $136,272 - $173,150	-595 Reduced 14.58%	3,485 $915,000
Q3 2022 Nov 08, 2022	SELL	$224.46 - $253.15 $59,930 - $67,591	-267 Reduced 6.14%	4,080 $920,000
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $461,650 - $513,736	-2,001 Reduced 31.52%	4,347 $1.06 Million
Q1 2022 May 13, 2022	SELL	$219.27 - $242.57 $54,817 - $60,642	-250 Reduced 3.79%	6,348 $1.54 Million
Q4 2021 Feb 07, 2022	SELL	$198.88 - $227.6 $13,523 - $15,476	-68 Reduced 1.02%	6,598 $1.48 Million
Q3 2021 Nov 10, 2021	BUY	$212.27 - $248.7 $23,561 - $27,605	111 Added 1.69%	6,666 $1.42 Million
Q2 2021 Aug 11, 2021	BUY	$233.58 - $259.14 $11,679 - $12,957	50 Added 0.77%	6,555 $1.6 Million
Q4 2020 Feb 08, 2021	BUY	$216.38 - $257.67 $64,914 - $77,301	300 Added 4.83%	6,505 $1.5 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $14,079 - $15,657	-60 Reduced 0.96%	6,205 $1.58 Million
Q2 2020 Aug 12, 2020	BUY	$197.81 - $242.74 $4,945 - $6,068	25 Added 0.4%	6,265 $1.48 Million
Q1 2020 May 06, 2020	SELL	$182.24 - $241.7 $21,868 - $29,004	-120 Reduced 1.89%	6,240 $1.27 Million
Q3 2019 Nov 07, 2019	SELL	$174.11 - $208.62 $487,508 - $584,136	-2,800 Reduced 30.57%	6,360 $1.23 Million
Q2 2019 Aug 13, 2019	BUY	$166.7 - $195.41 $52,843 - $61,944	317 Added 3.58%	9,160 $1.69 Million
Q1 2019 May 14, 2019	BUY	$180.87 - $203.88 $71,443 - $80,532	395 Added 4.68%	8,843 $1.68 Million
Q2 2018 Aug 14, 2018	SELL	$166.05 - $186.51 $11,623 - $13,055	-70 Reduced 0.82%	8,448 $1.56 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $33,886 - $39,600	-200 Reduced 2.29%	8,518 $1.45 Million
Q4 2017 Feb 14, 2018	SELL	$168.79 - $188.59 $3,375 - $3,771	-20 Reduced 0.23%	8,718 $1.52 Million
Q3 2017 Nov 14, 2017	BUY	$167.29 - $191.0 $414,042 - $472,725	2,475 Added 39.52%	8,738 $1.63 Million
Q2 2017 Aug 14, 2017	BUY	N/A	6,263	6,263 $1.08 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $138B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Compton Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Compton Capital Management Inc with notifications on news.

Account